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Abstract 
We have used an isolated chimeric protein E1340E2661 that includes the ectodomains of 
the envelope proteins of hepatitis C virus to study its interaction with model membranes. 
E1340E2661 has some of the membrane destabilization properties, vesicle aggregation, 
lipid mixing and the release of internal aqueous content, which has been previously 
ascribed to fusion proteins. The effects are preferentially produced on vesicles of acidic 
phospholipids which would indicate the importance of the electrostatic interactions. In 
fact, an increase of the ionic strength of the buffer induced a considerable decrease of the 
destabilizing properties. On the other hand, fluorescence polarization studies show that 
the recombinant protein reduces the amplitude of the thermal transition of DMPG 
vesicles and increases the transition temperature at pH 5.0 in a dose-dependent manner. 
These data would indicate an electrostatic interaction between the phospholipid polar 
head and the protein which eventually would lead to the insertion of E1340E2661 into the 
bilayer. On the other hand, a decrease of the pH induces a conformational change in the 
protein structure as evidenced by fluorescence of tryptophan residues and 4,4’-bis(1-
anilinonaphtalene 8-sulfonate. A model for the fusion of HCV with the host cell 
membrane can be postulated. The dissociation of E1E2 dimers would uncover the fusion 
peptides which can then interact with the polar lipid heads of the outer leaflet of the lipid 
bilayer and next insert into the hydrophobic moiety producing the destabilization of the 
bilayer which finally leads to fusion. 
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Introduction 
Hepatitis C virus (HCV) is an enveloped, positive-stranded RNA virus that 
belongs to the Hepacivirus genus of the Flaviviridae family [1, 2]. HCV is the major 
cause of acute hepatitis and chronic liver disease, including cirrhosis and hepatocellular 
carcinoma, being the leading cause of liver transplantations in the developed world. 
According to the World Health Organization, nowadays the HCV infects 180 million 
people worldwide, and every year 3 to 4 million of new cases emerge. Currently there is 
no vaccine available against HCV and the present therapy consists of interferonand 
ribavirin. However, only 10-20% of patients respond to interferon treatment and 54-56% 
to the combined therapy [3]. 
The HCV envelope glycoproteins, E1 (gp31) and E2 (gp70), are released from the 
polyprotein coded for by the HCV genome after cleavage by host-cell endoplasmic 
reticulum proteases in positions 383/384 and 746/747 of the sequence, respectively [4]. 
The amino acid sequence analysis of E1 and E2 indicates that they are type-I 
transmembrane proteins, highly glycosylated, with an N-terminal ectodomain and a C-
terminal hydrophobic domain anchoring these glycoproteins to the membrane. In vitro 
expression studies have shown that both glycoproteins associate to form a stable non-
covalently linked heterodimer which accumulates in the endoplasmic reticulum that has 
been proposed as the site for HCV assembly and budding [5]. However, recent studies 
carried out using cell-cultured HCV (HCVcc) show that the envelope glycoproteins E1 
and E2 form large covalent complexes stabilized by disulfide bridges in the virion [6]. 
Several molecules expressed on the cell surface have been implicated in HCV cell 
attachment. Thus, HCV has been shown to interact with the tetraspanin CD81 and the 
scavenger receptor class B type I (SR-BI). Also, claudins (claudin-1, claudin-6 and 
claudin-9) and occludin, proteins that are present in the tight junctions of the cells, have 
also been identified as key proteins in the HCV infection [7-9]. Other proposed co-factors 
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involved in the endocytosis of HCV are LDL receptor [10], C-type lectins DC-SIGN and 
L-SIGN [10, 11], glicosaminoglycans (GAGs) [12], and it has also been observed that the 
Ewi-2wint protein inhibits HCV infection by blocking the interaction of CD81 with the 
envelope glycoproteins of the virus [13].  
Besides their role in cellular receptor binding, the viral envelope proteins must 
induce fusion between the viral and host cell membranes. The difficulty of propagating 
HCV in cell culture has hampered for many years functional studies on HCV infection. 
The cellular mechanism of HCV entry has been studied using HCV pseudoparticles 
(HCVpp), infectious retroviral particles with HCV envelope proteins on the surface, and 
the cell culture model which allows for the production and propagation of virus in cell 
culture (HCVcc) [14-16]. Reports using both HCVpp and HCVcc models have evidenced 
the pH sensitivity of HCV entry [17-19]. Several studies suggest that HCV enters cells by 
clathrin-mediated endocytosis [17] and that fusion occurs in the early endosomes [20]. 
Furthermore, the acidic pH of endosomes triggers the fusion process probably by 
inducing conformational changes in the envelope proteins [17, 20-22]. 
Studies concerning the entry mechanism carried out with HCV isolated envelope 
proteins are scarce. Based on potential structural homology, E2 has been proposed as a 
Class II fusion protein [23]. Moreover, E1 has also been proposed as a candidate because 
sequence analyses suggest that it might contain a putative fusion peptide in its 
ectodomain [24, 25]. In relation to the location of the regions involved in the fusion 
process, some E1 and E2 peptides with a potential fusogenic activity have been identified 
[26, 27]. Although peptides might be a useful model to study the interaction of E2 with 
cellular membranes, a direct correlation with the fusion process in vivo is not always 
possible because of the lack of properties such as oligomerization or conformational 
changes. A directed mutagenesis study with HVCpp system has identified three important 
regions for the fusion with model vesicles [28]. The first one is located in E1 (residues 
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272 to 287) and the other two region are located in E2 (residues 419 to 433 and 597 to 
620). These data suggest that different E1 and E2 regions can cooperate for the fusion 
process. 
In order to shed light into the cell entry mechanism as well as into the protein and 
amino acid sequences involved on it, we have used a chimeric protein containing the E1 
and the E2 ectodomains connected by a small hydrophilic peptide (E1340E2661) and study 
its interaction with phospholipid vesicles. This chimeric protein obtained by baculovirus 
expression system has been previously shown to have the features of a correctly folded 
protein and it is recognized by HCV patient sera antibodies [29]. E1340E2661 is able to 
insert into the hydrophobic core of the bilayer inducing aggregation, lipid mixing and 
destabilization of the bilayers, which are the essential steps required for fusion [30]. 
Based on the results obtained, a model for the fusion activity of this chimeric protein is 
proposed.  
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Results 
E1340E2661 is able to induce destabilization of phospholipid vesicles 
Vesicle aggregation 
 The chimeric protein used throughout this study is composed of the two 
ectodomains of E1 and E2 HCV envelope glycoproteins (Fig. 1). This protein is 
produced in glycosylated form by insect cells infected by recombinant baculovirus, 
The recombinant protein has an oligomeric nature and is composed mainly of 
monomers, dimers and trimers [29]. Its ability to induce vesicle aggregation of PG, PS 
or PC liposomes was monitored by measuring the increment of the optical density at 
360 nm (OD360) as a result of the increase in vesicle size upon incubation with 
different concentrations of E1340E2661. The results obtained for the different 
phospholipids vesicles at various phospholipid/protein ratios at pH 5.0 and 100 mM 
NaCl are depicted in Fig. 2. In the presence of both PS and PG vesicles, the OD360 
value increased up to a phospholipid/protein ratio of 0.018, 2.5 M protein 
concentration, and then remained nearly constant. However, E1340E2661 induced little 
aggregation of PC vesicles. Therefore, the specificity toward negatively charged 
phospholipids points to the importance of the electrostatic component on the 
interaction which is on the other hand not dependent on the nature of the acidic polar 
head group. In fact when the experiment was performed at high salt concentration, 500 
mM, a reduction of almost 60% of the OD360 values reached at 100 mM was 
observed. Moreover, at neutral pH the changes in the OD360 observed with either 
phospholipid were almost negligible. The vesicles employed in these studies constitute 
a homogeneous population with an average size of 130 ± 40 nm as determined by 
dynamic light scattering. However, at the highest protein concentration used the 
vesicles became heterogeneous with an average size of 840 ± 500 nm. 
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As indicated by kinetic analysis performed at a protein/lipid molar ratio of 3.5 
x 10-3, the presence of 20 mol% cholesterol in acidic phospholipid vesicles resulted in 
an increase of almost 25% in vesicle aggregation at pH 5.0 produced by the 
recombinant protein (Fig. 3). A similar increase was observed at every protein/lipid 
molar ratio tested. Moreover, when vesicles composed of PC (36.8%), PE (20%), 
cholesterol (20%), sphingomyelin (13.6%), phosphatidylinositol (5.6%), PS (3.2%) 
and phosphatidic acid (0.8%), which resemble the plasma membranes of mouse 
hepatoma cells, similar results to those obtained with plain negatively charged vesicles 
were obtained. 
 
Lipid mixing 
 The ability of E1340E2661 to induce vesicle fusion, mixing of phospholipid vesicles 
was followed by the decrease in fluorescence resonance energy transfer (FRET) between 
the fluorescent probes NBD-PE and Rh-PE incorporated into a lipid matrix [31]. In this 
assay, the mixing of phospholipids from labelled and unlabelled liposomes results in an 
increase in the distance between the donor (NBD) and the acceptor (Rh), with the 
concomitant decrease in energy transfer (%FRET) which reflects accurately the degree of 
fusion. As it is observed in Fig. 4, E1340E2661 was able to induce lipid mixing of PG 
vesicles, both at pH 7.0 and 5.0, being the effect produced at neutral pH lower than that 
observed at acidic pH. At pH 5.0, %FRET decreased from 60%, in the absence of protein, 
to 7% at a protein/lipid ratio of 7 x 10-3. This value corresponds to a 9 fold dilution in 
acceptor surface density. This fact together with the considerable increase in vesicle size 
stated above argue in favour of the complete fusion of the vesicles, since their mere 
aggregation would not result in such a change in energy transfer [32]. When neutral 
phospholipids were used, a slight decrease in energy transfer was observed. 
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At neutral pH the presence of cholesterol has no effect on the lipid mixing of PG 
vesicles. However, at pH 5.0 and a protein/lipid ratio of 3.5 x 10-3 the presence of 20% 
cholesterol induced an additional decrease in the percentage of FRET, from 18% to 7%. 
These values correspond to a decrease in the acceptor surface density of 3.5 in the 
absence of cholesterol and almost 9 in its presence.  
 
Release of aqueous contents 
 The ability of E1340E2661 protein to destabilize the lipid bilayer was assessed by 
determining the release of aqueous contents of phospholipid vesicles. Liposome 
leakage was monitored by measuring the increase in ANTS fluorescence at 520 nm 
[33]. Fig. 5 shows the leakage induced by the recombinant protein when it is added to 
PG vesicles at pH 5.0 and 7.0. E1340E2661 was able to induce the release of internal 
contents of the vesicles in a dose-dependent manner. At a protein/lipid ratio of 0.45 x 
10-3, an 80% of Fmax is reached in both cases, and the 100% leakage was observed at a 
protein concentration of 0.33 M, concentration much lower than that needed to 
induce vesicle aggregation or lipid mixing (1.4-1.8 M). Then, there was no a pH-
dependence of the lipid destabilization as it was observed in the aggregation and lipid 
mixing assays. On the other hand, when the experiments were carried out at 500 mM 
NaCl a reduction of almost 35% of the leakage induced by the recombinant protein 
was observed. 
 
E1340E2661 interacts with phospholipid vesicles 
Fluorescence polarization 
To ascertain the interaction of E1340E2661 protein with acidic and neutral 
phospholipids, its effect on the thermotropic behaviour of the phospholipids has been 
studied by measuring the fluorescence polarization of these liposomes labelled in the 
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hydrophobic core of the bilayer with the fluorescent probe DPH. Fig. 6 shows the 
fluorescence depolarization of DPH-labelled DMPG vesicles with increasing 
temperatures in the presence of E1340E2661 protein a protein/phospholipid molar ratio of 
3.5 x 10-3 at pH 7.0 (Fig. 6A) and 5.0 (Fig. 6B). The addition of the recombinant protein 
to DMPG vesicles at acidic pH induced a slight decrease in the amplitude of the 
transition and an increase in the transition temperature. The effect on the fluorescence 
polarization was observed almost exclusively at temperatures above the transition 
temperature, indicating that the protein affected mainly the acyl chains in the liquid-
crystal phase, inducing a higher order in the chain packing (Fig. 6B). On the other hand, 
the fact that the amplitude of the phase transition was modified reveals the importance of 
the hydrophobic component in the interaction of E1340E2661 with phospholipids. The shift 
in the transition temperature indicates that the interaction of the recombinant protein with 
lipid membranes induces perturbations of the lipid packing due to the relative 
immobilization of phospholipid molecules around the protein. At temperatures below 
Tm, E1340E2661 is probably excluded from the ordered lipid phases and does not cause 
substantial effects on the packing of the phospholipid acyl chains. On the other hand, 
little changes in the transition curve were observed at pH 7.0 (Fig. 6A). Moreover, when 
neutral phospholipids (DMPC) vesicles were used no changes in the amplitude nor in the 
temperature of the transition were observed neither at neutral or acidic pH. 
 
Intrinsic and bis-ANS fluorescence spectroscopy studies 
  
The effect of both the pH change and the interaction with phospholipid vesicles 
on the protein structure was studied both by the use of tryptophan and bis-ANS 
fluorescence. The later is a compound with a high quantum yield in hydrophobic 
environments but which almost does not fluoresce in water. Hence it is widely used to 
detect conformational changes which expose hydrophobic regions of the protein structure 
[34]. The fluorescence spectrum of E1340E2661 at pH 7.0 shows a maximum at 331 nm 
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characteristic of Trp in a relatively low hydrophobic environment [29]. When the pH is 
brought to 5.0 a 20% decrease in the Trp quantum yield was observed (Fig. 7A), 
probably due to a higher exposure of Trp residues. The change is readily reversible since 
the spectrum obtained after adding NaOH to bring the pH back to 7.0 is indistinguishable 
of the initial one at that pH. The conformational change is also evidenced by the 
fluorescence of bis-ANS (Fig. 7B). The increase in fluorescence observed at pH 5.0 is 
indicative of the existence of new solvent-exposed hydrophobic surfaces in the protein, 
compatible with tryptophan residues in a more hydrophilic environment. Again, 
reversing the pH back to 7.0 recovered the bis-ANS fluorescence to its initial value. 
 Fig. 8 shows kinetic data of the effect of pH and the addition of PG on the 
fluorescence of bis-ANS when added to E1340E2661. The exposed hydrophobic areas 
which the recombinant protein possesses at pH 5.0 become almost instantaneously 
labelled by bis-ANS (Fig. 8A). As stated above part of them become buried when the pH 
is brought to 7.0 (Fig. 8A). However, when the protein in the presence of PG vesicles at 
pH 5.0 is incubated with bis-ANS, the fluorescence does not reach the value observed 
when the protein alone is incubated with the probe at pH 5.0 in the absence of 
phospholipids (Fig. 8B). This result could mean that most of the hydrophobic regions of 
the protein that become exposed at pH 5.0 are not accessible to bis-ANS in the presence 
of PG vesicles. In fact, when PG is added to bis-ANS labelled E1340E2661 at pH 5.0, the 
fluorescence reach a value close to that observed at pH 7.0 (Fig. 8C).   
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Discussion 
 
The knowledge of the HCV viral cycle is scarce and the sequence(s) involved in 
the fusion step between the host cell and the viral membranes have not yet been 
identified. By searching for classical features of fusion peptides through the protein 
sequence, several groups have identified some regions of HCV glycoproteins E1 and E2 
that could act as fusion peptides [26-28]. These regions may contribute to merging of 
viral and cellular membranes either by interacting directly with phospholipid membranes 
or by assisting the fusion process through their involvement in the conformational 
changes of E1E2 heterodimer at low pH. In this work, we have used an isolated chimeric 
protein E1340E2661 that includes the ectodomains of E1 and E2 envelope proteins to study 
the interaction and destabilization of lipid bilayers. This protein has been previously 
shown to have all the conformational features of a native protein [29]. Aggregation of 
phospholipid vesicles results showed that both the phospholipid nature and the pH are 
very important to ascertain the interaction of the recombinant protein with the 
phospholipids. Thus, E1340E2661 interacts preferentially with acidic phospholipids, PG or 
PS, at pH 5, although it is also able to interact with neutral phospholipid vesicles, PC, at 
this pH but to a much lower extent. Furthermore, this protein was also able to induce 
phospholipid mixing of acidic vesicles at pH 5.0 and the release of aqueous content of 
acidic vesicles at both neutral and acidic pH. The fact that the protein concentration at 
which E1340E2661 induces the last effect is considerably lower than that needed to induce 
aggregation and lipid mixing indicates that fusion is not necessary to destabilize the 
bilayer and induce the release of the aqueous contents. A similar behaviour has been 
described in other systems such as the amino-terminal peptide of HIV [35].  
The pH dependence of the fusogenic properties of the protein might indicate that, 
in vivo, infection might proceed through receptor mediated endocytosis. In this case, a 
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conformational change in the viral envelope glycoprotein induced by the acidic pH might 
be a prerequisite for membrane insertion and destabilization. Others authors have shown 
that HCV entry occurs in a pH-dependent manner via endocytosis. Thus, the use of drugs 
that inhibit endosomal acidification efficiently blocked HCVpp infection [18, 36-38]. 
Furthermore, low pH treatment of HCVpp led to the exposure of new epitopes in E2 
[39], supporting the notion that low pH induces conformational rearrangements in HCV 
glycoproteins, eventually leading to fusion with the endosome membrane. This would be 
consistent with a membrane fusion mechanism similar to that described for the 
glycoproteins of Flaviviruses, such as tick-borne encephalitis virus (TBEV) [40], dengue 
virus [41] and West Nile virus [42]. 
The dependence of the interaction on the nature of the polar head group indicates 
the importance of the electrostatic interactions. In fact, when these are diminished by 
increasing the salt concentration, a considerable reduction of all the destabilizing 
properties tested was observed. Analogous dependence with bilayer composition has 
been observed with other fusogenic viral peptides and proteins. In this sense, one of the 
features of the viral fusion mechanism is the variable requirement for specific lipids in 
the target cell membrane. For example, for simian immunodeficiency virus and HIV 
fusion peptides, lipid mixing occurs when there is PE in the lipid bilayer [43, 44]; 
vesicular stomatitis virus has a preference for PS [45], and influenza virus and Sendai 
virus peptides interact preferentially with PC membranes [46-48]. However, this 
dependence with the pH and the lipid composition observed in viral fusion proteins or 
even with whole viruses does not necessarily have a physiological significance. 
The effect of the recombinant protein on the transition temperature of DMPG 
vesicles at pH 5.0, as indicated by fluorescence polarization studies, is indicative of an 
electrostatic interaction at surface level, typical of peripheral proteins. Moreover, the 
decrease in transition amplitude is characteristic of integral membrane proteins [49], 
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suggesting that some protein regions are able to insert into the membrane interacting in a 
hydrophobic manner with the hydrocarbon core and restricting the mobility of the acyl 
chain. Thus, the interaction of E1340E2661 protein with the bilayer would take place in 
two steps: a first one governed by electrostatic interactions between the phospholipid 
polar head and the protein, and a second step driven by hydrophobic interactions which 
leads to the insertion of the protein into the bilayer. When the first step does not take 
place, such as when neutral phospholipids are used, the protein does not insert into the 
bilayer. Moreover, this mechanism of interaction would explain the differences observed 
with acidic phospholipids at pH 7.0 and 5.0 since an increment in positive charge as a 
consequence of the decrease of the pH would favour the initial step and hence the 
insertion into the bilayer.  
Cholesterol is a major component of mammalian membranes. When it 
incorporates into the bilayer, the main consequence is that it enhances lipid lateral 
interactions and it is able to locally induce negative membrane curvature [50]. It has been 
found that there is an important relationship between membrane fusion and cholesterol 
content for several viruses [51, 52]. In order to determine if this was also the case of 
HCV, we measured the ability of E1340E2661 to induce aggregation, lipid mixing and 
leakage of liposomes containing 20 mol% cholesterol. In all cases, a lower protein 
concentration was necessary to reach the highest destabilization when cholesterol-
containing vesicles were used. Thus, inclusion of cholesterol in liposomes, although it is 
not essential, facilitates fusion of HCV, which could indicate the involvement of lipid 
rafts in HCV entry. These results are consistent with other studies that have been 
performed with HCV. Thus, it has been described that the presence of cholesterol 
facilitates the fusion of HCVpp with the target membrane [18, 38] and enhances fusion of 
HCVcc [19]. On the other hand, it has been described that cholesterol affects the 
interaction of a peptide derived from the region 314-342 of E1 with liposomes, favouring 
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that the peptide positions close to the bilayer surface [53]. Also, in other Flaviviruses, 
cholesterol has been shown to enhance fusion [54]. Moreover, cholesterol has also been 
reported to enhance entry, but not the fusion process itself, of many other pH-dependent 
viruses [40]. In contrast, for alphaviruses such as the Semliki Forest (SFV) and Sindbis 
viruses, the presence of cholesterol in the target membrane is an absolute requirement for 
fusion to occur [51, 55-57]. 
The data on the conformational change induced by decreasing the pH and by the 
interaction with phospholipids allow us to propose the following model for the fusion of 
HCV. As a consequence of the diminution of the pH a shift to a more hydrophilic 
environment of some of the aromatic residues could have been produced. On the other 
hand, the acidic pH increases the surface hydrophobic area as monitored by bis-ANS. 
Taking into account that the interaction with phospholipid vesicles preserves the increase 
of bis-ANS fluorescence, it can be argued that the hydrophobic regions which become 
exposed as a consequence of acidification are those which become inserted into the 
bilayer impairing the interaction with bis-ANS molecules. These changes are compatible 
with a split of E1 and E2 ectodomains in the E1340E2661 chimera which could uncover the 
fusion peptides allowing their interaction with the polar lipid heads of the outer leaflet of 
the lipid bilayer and next insert into the hydrophobic moiety producing the destabilization 
of the bilayer which finally leads to fusion. This model is analogous to that observed with 
other class II fusion protein in which glycoproteins contact with surface at pH 7.0 
exposing aromatic side chains at the outer leaflet of the lipid bilayer [58, 59]. Next, a 
conformational change is observed at low pH which allows insertion of fusion peptides 
into the bilayer. This state precedes the opening of the fusion pore [60]. 
Therefore, the data presented herein indicated that E1340E2661 could serve as a 
good model to study the initial infective steps of HCV, allowing the location of those 
regions responsible for the interaction and the fusion with the cellular membrane. 
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Moreover, if this protein is involved in the fusion process it can be a good candidate to 
develop antiviral strategies to block viral infection. 
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Materials and methods 
 
Reagents 
  Synthetic phospholipids, dimyristoylphosphatidylcholine (DMPC), 
dimyristoylphosphatidylglycerol (DMPG), and natural phospholipids, egg 
phosphatidylcholine (PC), bovine brain phosphatidylserine (PS) and cholesterol were 
purchased from Avanti Polar Lipids (Birmingham, AL, USA). Egg yolk 
phosphatidylglycerol (PG) was obtained from SIGMA. N-(7-nitro-2,1,3-benzoxadiazol-
4-yl) dimyristoylphosphatidyl-ethanolamine (NBD-PE) and N-(lissamine rhodamine B 
sulphonyl) diacylphosphatidyl-ethanolamine (Rh-PE) were provided by Avanti Polar 
Lipids. 8-aminonaphthalene-1,3,6-trisulphonic acid (ANTS) and p-xylenebis-
(pyridinium) bromide (DPX) and 4,4’-bis(1-anilinonaphtalene 8-sulfonate (bis-ANS) 
were obtained from Molecular Probes. 1,6-diphenyl-1,3,5-hexatriene (DPH) was from 
Aldrich. 
 
Expression and purification of E1340E2661  
E1340E2661 was expressed and purified as described in [29]. Briefly, DNA 
encoding E1340E2661 was inserted into a baculovirus transfer vector pAcGP67A with 
the addition of a six-histidine tag. To produce the recombinant virus that expresses the 
protein, Sf9 insect cells were cotransfected with the recombinant vector and wild-type 
viral DNA. In a homologous recombination event, the E1340E2661 gene was inserted 
into the viral genome to generate the recombinant baculovirus. The protein was 
expressed by infecting High Five cells in Insect X-Press serum-free media with high 
titer virus (>108 pfu/ml) at MOI of 5-10. Medium was collected approximately 120 h 
postinfection, dialyzed against 20 mM Tris-HCl pH 8.0, 50 mM NaCl and loaded onto 
a Ni2+-nitrilotriacetic acid-agarose column (Qiagen) which had been previously 
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equilibrated with the same buffer. Once the protein solution had entered the column, it 
was washed with 10 mM imidazole and later with 30 mM imidazole in dialysis buffer. 
The recombinant E1340E2661 protein was eluted with 200 mM imidazole. The presence 
of E1340E2661 was monitored by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) which was performed according to Laemmli using 15% 
polyacrylamide gels [61]. By using this method approximately 2 mg of pure protein 
from 1 L of culture media were obtained [29]. 
 
Vesicle preparation 
 In all cases a lipid film was obtained by drying a chloroform:methanol (2:1) solution of 
the lipid under a current of nitrogen. This film was kept under vacuum 6-8 h. The 
phospholipids were resuspended at a concentration of 1 mg/ml in medium buffer (5 mM 
Tris-HCl, 100 mM NaCl, 5 mM MES, 5 mM sodium citrate, 1 mM EDTA) at the 
appropriate pH value for 1 h at 37 ºC and eventually vortexed vigorously. This 
suspension was sonicated in a bath sonicator (Branson 1200, Bransonic) and was 
subsequently subjected to 15 cycles of extrusion in an Extruder apparatus (LiposoFastTM-
Basic, Avestin) with 100 nm polycarbonate filters (Avestin). The size and size 
distribution of the vesicles were determined by dynamic light scattering on a Malvern 
Zetasizer Nano ZS instrument. 
   
Aggregation studies 
  The aggregation of phospholipid vesicles induced by the recombinant protein was 
studied by adding different amounts of protein to recently prepared lipid vesicles in 
medium buffer containing either 100 mM or 500 mM NaCl at the appropriate pH. The 
change in OD360 was measured on a Beckman DU-640 spectrophotometer after 
incubation for 1 h at 37ºC. The final phospholipid concentration was 0.14 mM. In all 
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cases, controls of lipid vesicles in the absence of protein and protein in absence of lipid 
were obtained.  
 
Lipid mixing assay 
  To follow the adhesion and fusion of lipid membranes induced by the protein we 
have used the classical fluorescent probe dilution assay [31], in which the decrease in 
efficiency of the fluorescence energy transfer between NBD-PE (energy donor) and Rh-
PE (energy acceptor) incorporated into liposomes, as a consequence of lipid mixing, is 
monitored. Liposomes, in medium buffer at the appropriate pH, labelled with 1 mol% 
NBD-PE and 0.6 mol% Rh-PE were mixed in a 1:9 molar ratio with unlabelled 
liposomes. Lipid mixing was initiated by the addition of the protein from a stock solution 
in 20 mM Tris pH, 7.5, NaCl 100 mM. The samples were incubated for 1 h at 37ºC and 
the emission spectra were recorded in a SLM AMINCO 8000C spectrofluorimeter, with 
the excitation wavelength set at 450 nm. Both the excitation and emission slits were set 
at 4 nm. The excitation polarizer was kept constant at 90º and the emission polarizer was 
kept constant at 0º to minimize dispersive interference. The efficiency of fluorescence 
resonance energy transfer was calculated from the ratio of the intensities at 530 and 590 
nm and the appropriate calibration curve which was obtained by using labelled vesicles 
containing 1% NBD-PE and variable concentrations of Rh-PE (between 0 and 1%). The 
final phospholipid concentration was 0.14 mM. 
 
Release of aqueous contents 
Leakage was determined by the ANTS/DPX assay [32] which is based on the 
dequenching of ANTS fluorescence caused by its dilution upon release of the aqueous 
contents of a vesicle population containing both ANTS and DPX. The assay was 
performed by coencapsulating 12.5 mM ANTS and 45 mM DPX in 10 mM Tris, pH 7.5, 
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20 mM NaCl or medium buffer, pH 5.0, in either PG or PC phospholipid vesicles. The 
lipid film was vortexed and the vesicles were sonicated in a bath for 15 min. Afterwards, 
the vesicles were subjected to five cycles of freeze-thawing in liquid nitrogen and passed 
at least 15 times through an Extruder apparatus (LiposoFastTM-Basic, Avestin) with 100 
nm polycarbonate filters (Avestin). After the vesicles with the coencapsulated probe and 
quencher had been formed, the whole sample was passed through a Sephadex G-75 
column (Pharmacia) to separate the vesicles from the nonencapsulated material using 10 
mM Tris, pH 7.5, 100 mM NaCl, 1 mM EDTA, or medium buffer, pH 5.0 for elution. 
The final phospholipid concentration in the assay was 0.14 mM. Both the excitation and 
emission slits were set at 4 nm. The excitation polarizer was kept constant at 90º and the 
emission polarizer was kept constant at 0º to minimize dispersive interference. Leakage 
was started by addition of the protein and the increase of the fluorescence emission at 
520 nm upon excitation at 385 nm was continuously recorded (Ft). The measurements 
were performed in a thermostated cell holder at 37 ºC. The fluorescence scale was set to 
100% by addition of 0.5% Triton X-100 and to 0%  by measuring the fluorescence of the 
control vesicles after the addition of equivalent volumes of buffer.  
 
Fluorescence polarization measurements 
 Fluorescence measurements were carried out on a SLM AMINCO 8000C 
spectrofluorimeter. Excitation and emission slit widths were 4 nm. Phospholipid vesicles 
were labelled with DPH in a probe:phospholipid ratio of 1:500. Emission spectra of DPH 
were measured at 425 nm with the excitation wavelength set at 365 nm, after 
equilibration of the sample at the required temperature. DMPG, or DMPC vesicles were 
incubated in the absence or in the presence of E1340E2661 at 37ºC for 30 min, using a lipid 
concentration of 0.14 mM and protein/lipid molar ratios of 1.75·10-3 and 3.5·10-3.  
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Intrinsic emission fluorescence 
Emission spectra of E1340E2661 protein were obtained at 37 ºC on a SLM 
AMINCO 8000C spectrofluorimeter. Excitation and emission slit widths were 4 nm. The 
protein concentration was 0.05 mgml-1 and a 0.4 x 1 cm cuvette was used. In all cases 
medium buffer at the appropriate pH value was used. Excitation was performed at 275 or 
295 nm, and the emission spectra were recorded over the range 285-450 nm. The 
contribution of the buffer with different concentrations of phospholipid vesicles was 
always subtracted. The excitation and emission polarizers were kept constant at 90º and 
0º to minimize dispersive interference. 
 
Extrinsic emission fluorescence 
The fluorescent probe bis-ANS was dissolved in methanol. The fluorescence 
emission spectra of bis-ANS were obtained on a SLM AMINCO 8000C 
spectrofluorimeter by using an excitation wavelength of 395 nm, and were recorded over 
the range 405-600 nm. Samples were prepared by adding 5 l of 0.2 mM bis-ANS to 
E1340E2661 in 5 mM sodium acetate, 5 mM MES, 5 mM Tris, 150 mM NaCl at the 
appropriate pH. These samples were incubated at 37 ºC for 5 min before the spectra were 
taken. Controls without protein and without protein and probe were obtained. 
 
Protein and phospholipid concentrations 
The UV-spectrum of the protein was routinely used to calculate the concentration 
of E1340E2661. An extinction coefficient (0.1% w/v, 1 cm, 280 nm) of 1.99 was used [29]. 
Lipid concentration was calculated based on their phosphorous content determined 
according to Barlett [62]. 
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Figure Legends 
 
Fig.1. Amino acid sequence of the chimeric protein E1340E2661. Positions 1-16 of the 
recombinant protein are introduced by the cloning procedure. Positions 17-166 and 181-
458 correspond to residues 192-341 and 384-661 of HCV E1 and E2 ectodomains 
respectively. The FLAG region which connects both ectodomains and which contains the 
enterokinase recognition sequence (DDDDK) is shown in bold [29]. The putative 
fusogenic sequences of both ectodomains are underlined [26]. The tryptophan residues of 
these fusogenic regions are highlighted. 
 
Fig. 2. Aggregation of PS,  PG, and PC phospholipid vesicles induced by E1340E2661. 
The increment of the optical density at 360 nm (OD360) was measured after the 
incubation of vesicles in medium buffer at pH 5.0 with E1340E2661 at different 
protein/lipid ratios. (●) PS  (■) PG  (▲) PC vesicles. The final phospholipid 
concentration was 0.14 mM. The results shown are the average ± SD of two different 
experiments. 
 
Fig. 3. Aggregation kinetic of vesicles induced by E1340E2661. PG vesicles in the 
absence (●, ■) or presence (○, □) of 20 % Chol were incubated with E1340E2661 at pH 
5.0. (○, ●) and pH 7.0 (□, ■). The optical density at 360 nm (OD360) was measured after 
the addition of the protein (arrow). The protein/lipid ratio was 3.5 x 10-3. The results 
shown are representative of those obtained for two different experiments. 
 
Fig. 4. Lipid mixing of PG vesicles induced by E1340E2661. Increasing concentrations 
of E1340E2661 were added to a 1:9 mixture of labelled (NBD-PE 1% and Rh-PE 1%) and 
unlabelled PG vesicles hydrated in medium buffer at pH 7.0 (○) or 5.0 (●). The 
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efficiency of fluorescence resonance energy transfer (FRET) was calculated from the 
ratio of the intensities at 530 and 590 nm and the appropriate calibration curve. The final 
phospholipid concentration was 0.14 mM. The results shown are the average ± SD of 
two different experiments. 
 
Fig. 5. Leakage of ANTS/DPX from PG vesicles induced by E1340E2661. Increasing 
concentrations of E1340E2661were added to vesicles loaded with ANTS and DPX in 
medium buffer at pH 7.0 (●) and 5.0 (■). Fmax was obtained upon addition of 0.5% Triton 
X-100. The measurements were performed at 37 ºC and the final phospholipid 
concentration in the assay was 0.14 mM. The results shown are the average ± SD of two 
different experiments. 
 
Fig. 6. Temperature dependence of fluorescence polarization of DPH-labelled 
DMPG liposomes. The vesicles were incubated with E1340E2661 at a protein/lipid molar 
ratio of 3.5 x 10-3 in medium buffer at pH 7.0 (A) and 5.0 (B). (●) DMPG vesicles alone  
(■) vesicles in the presence of the recombinant protein. The results shown are 
representative of those obtained for two different experiments. 
 
Fig. 7. Fluorescence emission spectra of E1340E2661 (A) and bis-ANS-E1340E2661 (B). 
The spectra were taken in medium buffer at pH 7.0 ( — ) and 5.0 ( - - - ) upon excitation 
at 275 (A) and 395 nm (B). The protein concentration was 0.05 mg/ml (A) and 0.025 
mg/ml (B). The results shown are representative of those obtained for two different 
experiments. 
 
Fig. 8. Change of emission fluorescence of bis-ANS. bis-ANS was added to E1340E2661 
at pH 5.0 in the absence (A) or in the presence (B) of PG vesicles or at pH 7.0 in absence 
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of lipid (C) and incubated at 37 ºC. The arrows indicate the time at which the 
corresponding compound was added. The addition of NaOH and HCl bring the pH back 
to 7.0 and 5.0, respectively. The protein/lipid molar ratio employed was 1.75 x 10-3. The 
excitation and emission wavelength were 395 and 495 respectively. The final 
concentration of bis-ANS was 2.5 M. The results shown are representative of those 
obtained for two different experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    1 ADPGYLLEFMHHHHHHYQVRNSTGLYHVTNDCPNSSIVYEAADAILHTPGCVPCVHEGNA 60 
 
   61 SRCWVALTPTVATRDGKLPTTQLRRHIDLLVGSATLCSALYVGDLCGSVFLVGQLFTFSP  120 
 
  121 RRHWTTQDCNCSIYPGHITGHRMAWDMMMNWSPTAALVVAQLLRIPDTKDDDDKAMGVDP  180 
 
  181 ETHVTGGTAAQTTAGLVSLLSPGAKQDIQLINTNGSWHINSTALNCNDSLYTGWLAGLFY  240 
 
  241 HHKFNSSGCPERFASCRPLTDFAQGWGPISHANGSGPDQRPYCWHYPPKPCGIVPAKSVC  300 
 
  301 GPVYCFTPSPVVVGTTDRSGAPTYSWGANDTDVFVLNNTRPPLGNWFGCTWMNSTGFTKV  360 
 
  361 CGAPPCVIGGVGNNTLHCPTDCFRKHPEATYSRCGSGPWITPRCLVNYPYRLWHYPCTIN  420 
 
  421 YTIFKVRMYVGGVEHRLEAACNWTRGERCNLEDRDRSERSHHHHHH  







